SynthesisDrug design, development and therapy2018

Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer.

Lilan Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.